HUTCHMED (China) Limited

HMDCF ·Healthcare, Drug Manufacturers - General
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014
Operating Activities
Net Income $-26.7M $11.7M $8.0M $-7.3M
Depreciation & Amortization $2.6M $2.3M $2.0M $1.3M
Depreciation $2.5M $2.2M $1.9M $1.2M
Amortization — — — —
Stock-Based Compensation — — — —
Net Cash from Operating Activities $-8.9M $-9.6M $-9.4M $8.4M
Investing Activities
Capital Expenditures $5.0M $4.3M $3.3M $3.7M
Business Acquisitions — — — —
Net Cash from Investing Activities $-260.8M $-33.6M $8.9M $-15.2M
Financing Activities
Dividends Paid — — — —
Stock Repurchases $1.4M $604.0K $1.8M —
Net Cash from Financing Activities $273.2M $92.4M $-5.5M $-641.0K
Net Change in Cash $5.8M $47.5M $-7.0M $-7.9M
Free Cash Flow $-14.0M $-13.9M $-12.7M $4.6M
← Newer Page 2 of 2 Older →